- Absci Corp (ABSI, Financial) will report its Q1 2025 financial results on May 13, 2025, after market close.
- The company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss results and future outlook.
- Investors can access the webcast live on Absci's investor relations website, with a replay available post-event.
Absci Corporation (ABSI), a leader in AI-driven drug creation, will release its financial and operational results for the first quarter of 2025 on May 13, 2025, after the market closes. Interested parties can tune into a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to learn about the company's developments, financial status, and future strategies.
The live audio of the webcast will be accessible via Absci's investor relations website at investors.absci.com. For those unable to attend the live presentation, a replay will be made available on the same platform shortly after the event concludes.
Absci's Integrated Drug Creation™ platform, which merges advanced AI models with a synthetic biology data engine, continues to drive rapid innovation in the field of drug discovery. The company's therapeutic pipeline features promising candidates like ABS-101 for inflammatory bowel disease and ABS-201 for hair regrowth, targeting androgenetic alopecia. With headquarters in Vancouver, WA, and facilities in New York City and Switzerland, Absci maintains a strong presence in the biotechnology sector.
